News SeaStar Medical Holding Corporation

Equities

ICU

US81256L1044

Market Closed - Nasdaq Other stock markets 01:30:00 01/06/2024 am IST			5-day change	1st Jan Change
0.3714 ^USD	+1.42%		-0.51%	-16.11%

14/05	SeaStar Medical Holding Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
30/04	SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility	22/05	AQ
SeaStar Medical Holding Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05	CI
SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update	15/05	AQ
SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure	30/04	AQ
SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure	30/04	CI
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU	28/04	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU	20/04	PR
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update	18/04	AQ
SeaStar Medical Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	17/04	CI
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU	12/04	PR
SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference	11/04	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU	05/04	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU	29/03	PR
SeaStar Medical : Non-Reliance on Previously Issued Financial Report - Form 8-K	27/03	PU
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17	27/03	AQ
SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients	12/03	AQ
Seastar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients	12/03	CI
SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024	12/03	AQ
SeaStar Medical : Investor Presentation March	01/03	PU
Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure	27/02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News SeaStar Medical Holding Corporation

Equities

ICU

US81256L1044

Summary

Filters